clinical trial · NCT06572982
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
Acute Myeloid LeukemiaAzacitidine
brief summary
Extension study, pilot, single-arm, compassionate use of Hikma Azacitidine 300 mg Film coated tablets test product for the Acute Myeloid Leukaemia (AML) patients who completed Hikma bioequivalence study with protocol number: HIK-AZA-2023-01
started
Apr 29, 2025
primary completion
May 1, 2026
completion
May 1, 2026
last updated
Jan 14, 2026
official title
Extension Study, Pilot, Single-arm, Compassionate Use of Hikma Azacitidine 300 mg Film Coated Tablets Test Product for the Acute Myeloid Leukaemia (AML) Patients Who Completed Hikma Bioequivalence Study With Protocol Number: HIK-AZA-2023-01
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol